Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$40.25 - $52.99 $245,042 - $322,603
6,088 New
6,088 $252,000
Q4 2023

Feb 09, 2024

SELL
$48.48 - $57.85 $54,152 - $64,618
-1,117 Reduced 16.98%
5,460 $280,000
Q2 2023

Aug 14, 2023

SELL
$63.71 - $70.74 $15,162 - $16,836
-238 Reduced 3.49%
6,577 $420,000
Q1 2023

May 10, 2023

SELL
$65.71 - $74.53 $6.82 Million - $7.73 Million
-103,714 Reduced 93.83%
6,815 $472,000
Q4 2022

Feb 14, 2023

BUY
$68.48 - $81.09 $33,007 - $39,085
482 Added 0.44%
110,529 $7.95 Million
Q3 2022

Nov 14, 2022

SELL
$0.13 - $76.84 $80 - $47,487
-618 Reduced 0.56%
110,047 $7.82 Million
Q2 2022

Aug 15, 2022

SELL
$72.62 - $79.98 $2.22 Million - $2.45 Million
-30,614 Reduced 21.67%
110,665 $8.52 Million
Q1 2022

May 16, 2022

SELL
$61.48 - $73.72 $4.14 Million - $4.96 Million
-67,275 Reduced 32.26%
141,279 $10.3 Million
Q4 2021

Feb 15, 2022

BUY
$53.63 - $62.52 $8.78 Million - $10.2 Million
163,747 Added 365.45%
208,554 $13 Million
Q3 2021

Nov 15, 2021

SELL
$59.17 - $69.31 $216,207 - $253,258
-3,654 Reduced 7.54%
44,807 $2.65 Million
Q2 2021

Aug 16, 2021

SELL
$61.91 - $67.42 $193,468 - $210,687
-3,125 Reduced 6.06%
48,461 $3.24 Million
Q1 2021

May 14, 2021

BUY
$59.34 - $66.74 $26,346 - $29,632
444 Added 0.87%
51,586 $3.26 Million
Q4 2020

Feb 12, 2021

BUY
$57.74 - $65.43 $247,242 - $280,171
4,282 Added 9.14%
51,142 $3.17 Million
Q3 2020

Nov 13, 2020

SELL
$57.43 - $63.64 $1.07 Million - $1.19 Million
-18,711 Reduced 28.54%
46,860 $2.83 Million
Q2 2020

Aug 13, 2020

BUY
$54.82 - $64.09 $468,711 - $547,969
8,550 Added 14.99%
65,571 $3.86 Million
Q1 2020

May 15, 2020

SELL
$46.4 - $67.43 $3.79 Million - $5.51 Million
-81,744 Reduced 58.91%
57,021 $3.18 Million
Q4 2019

Feb 14, 2020

BUY
$49.21 - $64.19 $5.47 Million - $7.13 Million
111,153 Added 402.55%
138,765 $8.91 Million
Q3 2019

Nov 14, 2019

SELL
$42.77 - $50.71 $5.21 Million - $6.18 Million
-121,778 Reduced 81.52%
27,612 $1.4 Million
Q2 2019

Aug 14, 2019

BUY
$44.62 - $49.34 $2.88 Million - $3.18 Million
64,551 Added 76.09%
149,390 $6.78 Million
Q1 2019

May 20, 2019

SELL
$45.12 - $53.8 $1.13 Million - $1.35 Million
-25,098 Reduced 22.83%
84,839 $4.05 Million
Q4 2018

Feb 13, 2019

BUY
$48.76 - $63.23 $5.36 Million - $6.95 Million
109,937 New
109,937 $5.72 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $124B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Allstate Corp Portfolio

Follow Allstate Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allstate Corp, based on Form 13F filings with the SEC.

News

Stay updated on Allstate Corp with notifications on news.